| Nov 11 |
Mirum Pharmaceuticals Q3 2024 Earnings Preview
|
| Nov 7 |
Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences
|
| Nov 6 |
High Growth Tech Stocks In The United States To Watch
|
| Nov 4 |
Mirum Pharmaceuticals to Announce Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024
|
| Oct 31 |
Will Mirum Pharmaceuticals, Inc. (MIRM) Report Negative Q3 Earnings? What You Should Know
|
| Oct 31 |
Mirum Pharmaceuticals to Showcase LIVMARLI Data from its ALGS and PFIC Programs at the NASPGHAN Annual Meeting
|
| Oct 23 |
Mirum Pharmaceuticals (MIRM): A Small-Cap Biotech with Strong Sales Growth
|
| Oct 10 |
Mirum’s liver disease drug candidate gets FDA breakthrough designation
|
| Oct 10 |
Volixibat Granted Breakthrough Therapy Designation for Cholestatic Pruritus in Primary Biliary Cholangitis
|
| Oct 9 |
Mirum Pharmaceuticals Inc (MIRM) Q2 2024 Earnings Call Highlights: Record Sales Surge and ...
|
